1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Radiation Oncology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Radiation Oncology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Radiation Oncology Market Regional Analysis
6.2 Europe Radiation Oncology Market Revenue 2021-2031 (US$ Million)
6.3 Europe Radiation Oncology Market Forecast Analysis
7. Europe Radiation Oncology Market Analysis – by Types
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Radiation Oncology Market Analysis – by Application
8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Head & Neck Cancer
- 8.4.1 Overview
- 8.4.2 Head & Neck Cancer: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cervical Cancer
- 8.5.1 Overview
- 8.5.2 Cervical Cancer: Europe Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Radiation Oncology Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Radiation Oncology Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 9.2.1.1 Europe Radiation Oncology Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.1.1 UK: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.1.2 UK: Europe Radiation Oncology Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.2.1 Germany: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.2.2 Germany: Europe Radiation Oncology Market Breakdown, by Application
- 9.2.1.3 France:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.3.1 France: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.3.2 France: Europe Radiation Oncology Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.4.1 Russia: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.4.2 Russia: Europe Radiation Oncology Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.5.1 Italy: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.5.2 Italy: Europe Radiation Oncology Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Radiation Oncology Market Breakdown, by Types
- 9.2.1.6.2 Rest of Europe: Europe Radiation Oncology Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Varian Medical Systems Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elekta AB.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Accuray Incorporated.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 IBA Worldwide (Ion Beam Applications SA).
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Becton Dickinson and Co.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Nordion.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Mevion Medical Systems.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 NTP RADIOISOTOPES.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Mallinckrodt Plc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Curium.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations